Steven Edmundowicz
Concepts (480)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiopancreatography, Endoscopic Retrograde | 39 | 2025 | 219 | 3.860 |
Why?
| | Endoscopy, Gastrointestinal | 29 | 2023 | 237 | 3.510 |
Why?
| | Endosonography | 31 | 2025 | 157 | 2.060 |
Why?
| | Esophageal Neoplasms | 14 | 2026 | 349 | 1.810 |
Why?
| | Bariatric Surgery | 12 | 2019 | 242 | 1.730 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 140 | 1.660 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 927 | 1.530 |
Why?
| | Adenoma | 12 | 2023 | 218 | 1.420 |
Why?
| | Endoscopy | 13 | 2020 | 316 | 1.420 |
Why?
| | Pancreatitis | 14 | 2025 | 145 | 1.330 |
Why?
| | Gastric Balloon | 6 | 2018 | 17 | 1.300 |
Why?
| | Weight Loss | 11 | 2019 | 837 | 1.280 |
Why?
| | Obesity | 17 | 2019 | 3082 | 1.250 |
Why?
| | Stents | 20 | 2025 | 556 | 1.220 |
Why?
| | Gastroplasty | 5 | 2019 | 32 | 1.220 |
Why?
| | Barrett Esophagus | 11 | 2026 | 165 | 1.210 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 10 | 2025 | 60 | 1.210 |
Why?
| | Adenocarcinoma | 14 | 2026 | 931 | 1.210 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 136 | 1.080 |
Why?
| | Pancreatic Ducts | 11 | 2024 | 81 | 0.990 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 260 | 0.970 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 128 | 0.960 |
Why?
| | Drainage | 12 | 2024 | 185 | 0.950 |
Why?
| | Colonic Polyps | 7 | 2015 | 85 | 0.890 |
Why?
| | Gastroenterology | 10 | 2019 | 189 | 0.890 |
Why?
| | Colonoscopy | 12 | 2023 | 261 | 0.870 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 236 | 0.840 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 128 | 0.750 |
Why?
| | Cholestasis | 3 | 2020 | 219 | 0.690 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 216 | 0.680 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.650 |
Why?
| | Duodenum | 4 | 2019 | 77 | 0.650 |
Why?
| | Pancreatitis, Chronic | 5 | 2024 | 63 | 0.640 |
Why?
| | Esophagus | 8 | 2019 | 261 | 0.630 |
Why?
| | Pancreatic Pseudocyst | 5 | 2024 | 18 | 0.620 |
Why?
| | Humans | 163 | 2026 | 144957 | 0.610 |
Why?
| | Middle Aged | 95 | 2026 | 35928 | 0.610 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 66 | 0.610 |
Why?
| | Obesity, Morbid | 7 | 2019 | 281 | 0.610 |
Why?
| | Esophagoscopy | 9 | 2026 | 221 | 0.600 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 31 | 0.600 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 68 | 0.590 |
Why?
| | Indomethacin | 4 | 2025 | 76 | 0.590 |
Why?
| | Catheterization | 9 | 2024 | 183 | 0.580 |
Why?
| | Aged | 74 | 2026 | 25947 | 0.570 |
Why?
| | Clinical Competence | 11 | 2020 | 1244 | 0.540 |
Why?
| | Learning Curve | 6 | 2019 | 70 | 0.520 |
Why?
| | Cross Infection | 1 | 2020 | 262 | 0.520 |
Why?
| | Prospective Studies | 37 | 2026 | 7997 | 0.510 |
Why?
| | Radiation Exposure | 1 | 2017 | 63 | 0.510 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2026 | 1141 | 0.510 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 38 | 0.510 |
Why?
| | Intestine, Small | 2 | 2020 | 166 | 0.500 |
Why?
| | Gastrostomy | 5 | 2019 | 130 | 0.500 |
Why?
| | Colonic Diseases | 3 | 2013 | 34 | 0.490 |
Why?
| | Radiation Injuries | 1 | 2017 | 151 | 0.480 |
Why?
| | Jejunum | 2 | 2015 | 35 | 0.480 |
Why?
| | Treatment Outcome | 37 | 2026 | 11695 | 0.480 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 17 | 0.460 |
Why?
| | Smell | 1 | 2016 | 128 | 0.460 |
Why?
| | Male | 96 | 2026 | 72406 | 0.450 |
Why?
| | Pathology, Clinical | 1 | 2015 | 29 | 0.450 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 70 | 0.450 |
Why?
| | Cholelithiasis | 8 | 2010 | 36 | 0.440 |
Why?
| | Pancreas | 7 | 2021 | 342 | 0.440 |
Why?
| | Lithotripsy | 6 | 2024 | 49 | 0.440 |
Why?
| | Female | 98 | 2026 | 78376 | 0.440 |
Why?
| | Laparoscopy | 6 | 2020 | 475 | 0.430 |
Why?
| | Suction | 2 | 2017 | 33 | 0.430 |
Why?
| | Catheter Ablation | 5 | 2022 | 353 | 0.400 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 104 | 0.400 |
Why?
| | Gallstones | 6 | 1996 | 35 | 0.400 |
Why?
| | Postoperative Complications | 11 | 2024 | 2920 | 0.370 |
Why?
| | Adult | 61 | 2025 | 40506 | 0.370 |
Why?
| | Propofol | 4 | 2023 | 85 | 0.360 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1990 | 0.360 |
Why?
| | Body Weight | 1 | 2016 | 978 | 0.360 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 4 | 2025 | 338 | 0.350 |
Why?
| | Aged, 80 and over | 24 | 2025 | 8279 | 0.350 |
Why?
| | Biopsy | 5 | 2019 | 1077 | 0.350 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2584 | 0.350 |
Why?
| | Gastroscopy | 4 | 2014 | 18 | 0.340 |
Why?
| | Precancerous Conditions | 4 | 2017 | 166 | 0.340 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 848 | 0.330 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 335 | 0.330 |
Why?
| | Bile Ducts | 5 | 2014 | 67 | 0.330 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 50 | 0.310 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 26 | 0.310 |
Why?
| | Cytodiagnosis | 2 | 2020 | 31 | 0.310 |
Why?
| | Ampulla of Vater | 3 | 2023 | 39 | 0.310 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 14 | 0.300 |
Why?
| | Insufflation | 1 | 2009 | 13 | 0.300 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 248 | 0.300 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 323 | 0.290 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 27 | 0.280 |
Why?
| | Retrospective Studies | 36 | 2025 | 17101 | 0.280 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 56 | 0.280 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 54 | 0.280 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.260 |
Why?
| | Carbon Dioxide | 1 | 2009 | 242 | 0.260 |
Why?
| | Follow-Up Studies | 17 | 2026 | 5417 | 0.260 |
Why?
| | Decompression, Surgical | 2 | 2023 | 117 | 0.260 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 153 | 0.250 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 40 | 0.250 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 29 | 0.250 |
Why?
| | Quality of Life | 11 | 2024 | 3192 | 0.240 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 13 | 0.240 |
Why?
| | Thoracoscopy | 1 | 2006 | 62 | 0.230 |
Why?
| | Body Mass Index | 7 | 2019 | 2438 | 0.230 |
Why?
| | Pancreatectomy | 2 | 2021 | 285 | 0.230 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 114 | 0.220 |
Why?
| | Mental Recall | 1 | 2006 | 222 | 0.220 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 14 | 0.210 |
Why?
| | Polyvinyls | 1 | 2004 | 20 | 0.210 |
Why?
| | Magnets | 2 | 2015 | 21 | 0.210 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 466 | 0.210 |
Why?
| | Plastics | 3 | 2022 | 47 | 0.210 |
Why?
| | Societies, Medical | 3 | 2018 | 887 | 0.210 |
Why?
| | Lymphoma | 1 | 2025 | 233 | 0.210 |
Why?
| | Periodicals as Topic | 1 | 2006 | 203 | 0.200 |
Why?
| | Gastric Bypass | 2 | 2017 | 125 | 0.200 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2025 | 192 | 0.190 |
Why?
| | Ablation Techniques | 3 | 2017 | 36 | 0.190 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.190 |
Why?
| | Fluoroscopy | 3 | 2019 | 176 | 0.180 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 208 | 0.180 |
Why?
| | Internet | 2 | 2009 | 700 | 0.180 |
Why?
| | Patient Satisfaction | 1 | 2006 | 705 | 0.180 |
Why?
| | Prostheses and Implants | 3 | 2013 | 141 | 0.180 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 16 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 292 | 0.170 |
Why?
| | Deglutition Disorders | 3 | 2019 | 147 | 0.170 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 39 | 0.170 |
Why?
| | Intestinal Perforation | 2 | 2018 | 44 | 0.160 |
Why?
| | Risk Factors | 14 | 2025 | 10792 | 0.160 |
Why?
| | Varicose Veins | 1 | 2020 | 16 | 0.160 |
Why?
| | Logistic Models | 7 | 2024 | 2119 | 0.160 |
Why?
| | Prosthesis Design | 3 | 2019 | 357 | 0.160 |
Why?
| | Double-Blind Method | 7 | 2018 | 2029 | 0.160 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 36 | 0.160 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 33 | 0.160 |
Why?
| | Anesthesia | 1 | 2023 | 258 | 0.150 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1465 | 0.150 |
Why?
| | Equipment Design | 6 | 2020 | 530 | 0.150 |
Why?
| | Cell-Free System | 1 | 2019 | 53 | 0.150 |
Why?
| | Deep Sedation | 2 | 2010 | 16 | 0.150 |
Why?
| | Abdominal Pain | 3 | 2019 | 146 | 0.150 |
Why?
| | Fiducial Markers | 1 | 2019 | 9 | 0.150 |
Why?
| | Urinary Calculi | 1 | 2019 | 10 | 0.150 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 39 | 0.150 |
Why?
| | Needles | 1 | 2019 | 62 | 0.140 |
Why?
| | Watchful Waiting | 3 | 2019 | 89 | 0.140 |
Why?
| | Academic Medical Centers | 3 | 2023 | 548 | 0.140 |
Why?
| | Infection Control | 1 | 2020 | 172 | 0.140 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 57 | 0.140 |
Why?
| | Metals | 4 | 2023 | 142 | 0.140 |
Why?
| | Recurrence | 5 | 2026 | 1135 | 0.140 |
Why?
| | Incidence | 7 | 2026 | 2883 | 0.140 |
Why?
| | Administration, Rectal | 3 | 2024 | 13 | 0.140 |
Why?
| | Abdomen | 2 | 2016 | 141 | 0.130 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.130 |
Why?
| | Time Factors | 10 | 2026 | 7183 | 0.130 |
Why?
| | Obesity Management | 1 | 2017 | 7 | 0.130 |
Why?
| | Aneurysm, False | 1 | 2018 | 45 | 0.130 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3415 | 0.130 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 11 | 0.130 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 12 | 0.130 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 95 | 0.130 |
Why?
| | Suture Techniques | 3 | 2017 | 131 | 0.130 |
Why?
| | Calcinosis | 1 | 2019 | 234 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 135 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2023 | 783 | 0.130 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 108 | 0.130 |
Why?
| | Simulation Training | 1 | 2019 | 134 | 0.130 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 97 | 0.120 |
Why?
| | Diet Therapy | 1 | 2016 | 37 | 0.120 |
Why?
| | Metaplasia | 4 | 2022 | 57 | 0.120 |
Why?
| | Immunoassay | 1 | 2017 | 109 | 0.120 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1054 | 0.120 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 557 | 0.120 |
Why?
| | Stomach | 1 | 2016 | 109 | 0.120 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 326 | 0.120 |
Why?
| | Population Surveillance | 2 | 2017 | 485 | 0.120 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 28 | 0.120 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.120 |
Why?
| | Single-Blind Method | 5 | 2019 | 312 | 0.110 |
Why?
| | Young Adult | 11 | 2025 | 14126 | 0.110 |
Why?
| | Life Style | 2 | 2018 | 479 | 0.110 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 82 | 0.110 |
Why?
| | Colon, Ascending | 1 | 2015 | 3 | 0.110 |
Why?
| | Dissection | 1 | 2015 | 56 | 0.110 |
Why?
| | Dogs | 1 | 2016 | 438 | 0.110 |
Why?
| | Documentation | 1 | 2017 | 199 | 0.110 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 58 | 0.110 |
Why?
| | Referral and Consultation | 3 | 2019 | 853 | 0.110 |
Why?
| | Cholecystectomy | 4 | 2009 | 59 | 0.110 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 676 | 0.110 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 357 | 0.110 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 109 | 0.110 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.110 |
Why?
| | Pilot Projects | 2 | 2013 | 1890 | 0.110 |
Why?
| | Aptitude | 1 | 2014 | 31 | 0.110 |
Why?
| | Leiomyoma | 1 | 2015 | 59 | 0.110 |
Why?
| | Hospitalization | 1 | 2025 | 2434 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 27 | 0.110 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1540 | 0.100 |
Why?
| | Ulcer | 1 | 2014 | 37 | 0.100 |
Why?
| | Colectomy | 1 | 2014 | 107 | 0.100 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 288 | 0.100 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1322 | 0.100 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 2118 | 0.100 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 26 | 0.100 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 24 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 349 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Community Health Services | 1 | 2014 | 234 | 0.090 |
Why?
| | Hemorrhage | 1 | 2018 | 809 | 0.090 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 13 | 0.090 |
Why?
| | Contrast Media | 1 | 1995 | 488 | 0.090 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 160 | 0.090 |
Why?
| | Cholecystitis | 1 | 1992 | 23 | 0.090 |
Why?
| | Health Care Costs | 1 | 2015 | 427 | 0.090 |
Why?
| | Risk Assessment | 8 | 2016 | 3676 | 0.090 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 3 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2012 | 502 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 1991 | 8 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2016 | 473 | 0.090 |
Why?
| | Digestive System Diseases | 1 | 2011 | 27 | 0.090 |
Why?
| | Diverticulum | 1 | 1991 | 14 | 0.090 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1495 | 0.090 |
Why?
| | Esophageal Diseases | 1 | 1991 | 30 | 0.090 |
Why?
| | Sensation | 1 | 1991 | 55 | 0.080 |
Why?
| | Chest Pain | 1 | 1991 | 100 | 0.080 |
Why?
| | Deglutition | 1 | 1991 | 72 | 0.080 |
Why?
| | Hypotension | 1 | 2011 | 126 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2925 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 589 | 0.080 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 5 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1991 | 153 | 0.080 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.080 |
Why?
| | Image Enhancement | 1 | 2011 | 199 | 0.080 |
Why?
| | Bile | 1 | 2009 | 26 | 0.080 |
Why?
| | Cholecystostomy | 1 | 1989 | 3 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1195 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1563 | 0.080 |
Why?
| | United States | 10 | 2018 | 15988 | 0.080 |
Why?
| | Disease Progression | 5 | 2017 | 2852 | 0.080 |
Why?
| | Odds Ratio | 4 | 2016 | 1077 | 0.080 |
Why?
| | Length of Stay | 5 | 2025 | 1337 | 0.070 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 79 | 0.070 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 97 | 0.070 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 52 | 0.070 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 47 | 0.070 |
Why?
| | Equipment Safety | 2 | 2009 | 38 | 0.070 |
Why?
| | Tumor Burden | 3 | 2015 | 322 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 56 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 164 | 0.070 |
Why?
| | Cholangiography | 1 | 2008 | 10 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 4099 | 0.070 |
Why?
| | Anesthetics | 1 | 2009 | 99 | 0.070 |
Why?
| | Choledocholithiasis | 1 | 2008 | 20 | 0.070 |
Why?
| | Adolescent | 8 | 2025 | 22453 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 340 | 0.070 |
Why?
| | Ultrasonography | 4 | 1996 | 770 | 0.070 |
Why?
| | Video Recording | 3 | 2014 | 213 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 685 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 396 | 0.070 |
Why?
| | Biopsy, Needle | 2 | 2004 | 183 | 0.060 |
Why?
| | Acute Disease | 4 | 2008 | 1031 | 0.060 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 343 | 0.060 |
Why?
| | Hyperplasia | 2 | 2019 | 174 | 0.060 |
Why?
| | Pleural Diseases | 1 | 2006 | 23 | 0.060 |
Why?
| | Lymphoma, B-Cell, Marginal Zone | 1 | 2025 | 19 | 0.060 |
Why?
| | Research Design | 2 | 2016 | 1137 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2385 | 0.060 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 35 | 0.060 |
Why?
| | Prognosis | 5 | 2017 | 4293 | 0.060 |
Why?
| | Lymphoma, Follicular | 1 | 2025 | 56 | 0.060 |
Why?
| | Pain | 2 | 2022 | 782 | 0.060 |
Why?
| | Delphi Technique | 2 | 2017 | 331 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 9 | 0.060 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.060 |
Why?
| | Health Care Surveys | 3 | 2014 | 539 | 0.050 |
Why?
| | Hospital Units | 1 | 2004 | 32 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2025 | 132 | 0.050 |
Why?
| | Cohort Studies | 5 | 2020 | 5965 | 0.050 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 80 | 0.050 |
Why?
| | Cyst Fluid | 2 | 2018 | 20 | 0.050 |
Why?
| | Hypoxia | 1 | 2011 | 1199 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 189 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 6053 | 0.050 |
Why?
| | Diphenhydramine | 1 | 2023 | 36 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 642 | 0.050 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 140 | 0.050 |
Why?
| | Midazolam | 1 | 2023 | 72 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 66 | 0.050 |
Why?
| | Observer Variation | 2 | 2014 | 355 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 24 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 36 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 127 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2026 | 1325 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 555 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 244 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 16 | 0.040 |
Why?
| | Animals | 3 | 2020 | 38109 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2015 | 268 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 216 | 0.040 |
Why?
| | Mass Screening | 1 | 2010 | 1348 | 0.040 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 29 | 0.040 |
Why?
| | Endoscopes | 2 | 1998 | 17 | 0.040 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 63 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2884 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2738 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 252 | 0.040 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 121 | 0.040 |
Why?
| | Silicones | 1 | 2020 | 29 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 38 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1268 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 51 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 76 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 54 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 91 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 44 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 321 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 36 | 0.040 |
Why?
| | Feasibility Studies | 2 | 2018 | 1095 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1054 | 0.030 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 76 | 0.030 |
Why?
| | Probability | 2 | 2009 | 312 | 0.030 |
Why?
| | Electrosurgery | 1 | 1998 | 42 | 0.030 |
Why?
| | Electrodes | 1 | 1998 | 115 | 0.030 |
Why?
| | Radiology | 1 | 2000 | 175 | 0.030 |
Why?
| | Reference Standards | 1 | 2018 | 178 | 0.030 |
Why?
| | Swine | 1 | 2020 | 833 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1416 | 0.030 |
Why?
| | General Surgery | 1 | 2000 | 207 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2018 | 51 | 0.030 |
Why?
| | Resuscitation | 1 | 2000 | 302 | 0.030 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 96 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1358 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 427 | 0.030 |
Why?
| | Granulation Tissue | 1 | 2016 | 6 | 0.030 |
Why?
| | Manometry | 2 | 2001 | 97 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 76 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 192 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 3 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 84 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 9 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 17 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 14 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 15 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 218 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 32 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 28 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 12 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1143 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 6 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 81 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2836 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 41 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 84 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 2092 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 121 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 167 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 129 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2947 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 82 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 137 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 489 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 220 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11799 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 689 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 80 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 489 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 299 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 282 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 333 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 80 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3869 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1177 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 230 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 289 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2014 | 166 | 0.020 |
Why?
| | Lipids | 1 | 2018 | 710 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 1995 | 216 | 0.020 |
Why?
| | Patient Participation | 1 | 2017 | 433 | 0.020 |
Why?
| | Medicaid | 1 | 2017 | 462 | 0.020 |
Why?
| | ROC Curve | 1 | 2015 | 615 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1327 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 732 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 949 | 0.020 |
Why?
| | Patient Selection | 1 | 2017 | 719 | 0.020 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 5 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 636 | 0.020 |
Why?
| | Colic | 1 | 1992 | 8 | 0.020 |
Why?
| | Esophagitis | 1 | 2013 | 66 | 0.020 |
Why?
| | Radio Waves | 2 | 2003 | 28 | 0.020 |
Why?
| | Mediastinum | 1 | 2012 | 23 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2013 | 127 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2018 | 916 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 887 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1769 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 200 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 69 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 12 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 456 | 0.020 |
Why?
| | Edema | 1 | 2011 | 124 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 17 | 0.020 |
Why?
| | Palliative Care | 1 | 2019 | 1008 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 202 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 22 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 314 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 8 | 0.020 |
Why?
| | Methods | 1 | 1989 | 69 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 380 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 40 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1275 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 845 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 561 | 0.020 |
Why?
| | Injections | 1 | 2010 | 197 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 798 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 541 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 11 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 72 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 966 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 403 | 0.020 |
Why?
| | Light | 1 | 2011 | 411 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 386 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 284 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 429 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 151 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 207 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 162 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 253 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3335 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 186 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 156 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 980 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 249 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 339 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 121 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1385 | 0.010 |
Why?
| | Thoracic Surgery | 1 | 2008 | 144 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2008 | 1311 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 623 | 0.010 |
Why?
| | Exercise | 1 | 2017 | 2201 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1718 | 0.010 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 5872 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1660 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 98 | 0.010 |
Why?
| | Child | 2 | 2018 | 22657 | 0.010 |
Why?
| | Infant | 1 | 2018 | 10039 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2114 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 61 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 6 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 631 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 1186 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 49 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 106 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 1026 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 115 | 0.010 |
Why?
| | Safety | 1 | 1998 | 356 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 49 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 144 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 126 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 4 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 12 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 663 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 113 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 119 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 187 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1813 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 7191 | 0.000 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|